AGW-11 is a potent dual inhibitor that targets EGFR (IC50 = 556 nM) and VEGFR2 (IC50 = 289.7 nM). It induces apoptosis and inhibits the phosphorylation of EGFR, VEGFR2, and ERK1/2 in HUVECs. AGW-11 effectively suppresses cancer cell growth, reduces HUVEC proliferation, tube formation, and invasion, thus blocking angiogenesis. In 4T1 xenograft mouse models, AGW-11 significantly inhibits tumor growth and reduces lung metastasis. AGW-11 is applicable in breast cancer research.
Target:
Apoptosis|||VEGFR|||ERK|||EGFR
* VAT and and shipping costs not included. Errors and price changes excepted
